SA
Samuel Agresta
Internal Medicine
Credentials: ·
History
Hematology and Medical Oncology
Internal Medicine
Research
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
New England Journal of Medicine · 2018 · 1,234 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,232 citations
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
Science · 2013 · 687 citations
8 papers · 1 as a fellow
7 papers
- ES
7 papers
- EA
6 papers
- DS
5 papers
5 papers
- MT
5 papers
5 papers
